Search Results for 'CRO'

Contract Service Directory Companies

View All Buyers Guide Companies »

Contract Service Directory Categories

View All Categories »

• Breaking News | Clinical Trials | CRO News
  

  Emmes Acquires Orphan Reach

  Establishes Emmes as an industry leader in clinical research for orphan and rare diseases.

  Kristin Brooks 05.12.21
  

  ---

• Breaking News | Industry News
  

  Angelini Fine Chemicals Invests in Flow Chemistry & Micro-Reaction Technology

  Reacts to the rising number of new active pharmaceutical ingredients that require specialized and niche chemistry.

  Charles Sternberg, Assistant Editor 05.11.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
  

  FDA Expands EUA for Pfizer, BioNTech’s Covid-19 Vax

  Expands the authorization to include individuals 12-15 years of age.

  Charles Sternberg, Assistant Editor 05.11.21
  

  ---

• Breaking News | Drug Development | R&D
  

  Crown Bioscience Acquires OcellO

  Expands its portfolio of in vitro services.

  Charles Sternberg, Assistant Editor 05.06.21
  

  ---

• Analytical Services | Clinical Trials | Information Technology
  

  Implications of COVID-19 on Statistical Design and Analyses of Clinical Studies

  A look at the challenges and risks to statistical integrity and how they can be mitigated.

  Tim Victor, Head of Biostatistics, Clinical Research Services, ICON plc 05.05.21
  

  ---

• Breaking News | Clinical Trials | CRO News | Information Technology
  

  Syneos, Komodo Health Expand Data App Alliance

  Leveraging Komodo’s Healthcare Map, Syneos aims to better analyze clinical, real-world, and commercial data.

  Kristin Brooks 05.04.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Industry News
  

  Moderna to Increase Global Supply for COVID-19 Vaccine

  Will supply up to 3 billion doses in 2022 and double supply from ex-U.S. supply chain.

  Tim Wright, Editor, Contract Pharma 05.03.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Fill/Finish | Industry News
  

  Sanofi, Moderna Enter COVID-19 Vaccine Fill/Finish Manufacturing Deal

  Sanofi will provide fill/finish services for up to 200 million doses of Moderna’s COVID-19 vaccine in the U.S. beginning in September 2021.

  Tim Wright, Editor, Contract Pharma 05.03.21
  

  ---

• Breaking News | Facilities | Fill/Finish | Industry News
  

  Grand River Aseptic Manufacturing Earns Facility of the Year Award

  Receives special recognition for operational agility during the pandemic.

  Charles Sternberg, Assistant Editor 04.29.21
  

  ---

• Analytical Services | Bioanalytical Services | Breaking News | CRO News | Facilities | Industry News
  

  PPD to Expand GMP Lab in Ireland

  Adding cell and gene therapy capabilities to support growing customer need.

  Tim Wright, Editor, Contract Pharma 04.29.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
  

  Lonza Doubles Drug Substance Production for Moderna’s COVID-19 Vaccine

  New agreement for three additional production lines at Lonza’s site in Visp, Switzerland.

  Tim Wright, Editor, Contract Pharma 04.29.21
  

  ---

• Clinical Trials | CRO News | Information Technology
  

  PPD, Science 37 Partner to Advance Decentralized Trials

  PPD will leverage Science 37's DCT SaaS-based technology platform to design, build, test, implement and execute digital trials.

  Kristin Brooks 04.28.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
  

  RDIF, Minapharm to Make Over 40M Doses of the Sputnik V Vaccine in Egypt

  Production will take place in Minapharm’s biotech facility in Cairo for global distribution.

  Tim Wright, Editor, Contract Pharma 04.23.21
  

  ---

• Clinical Trials | CRO News | Information Technology
  

  Syneos, Medable Partner for New Decentralized Capabilities

  Aims to increase clinical trial diversity and improve patient access and experiences with fit-for-purpose decentralized digital solution.

  Kristin Brooks 04.22.21
  

  ---

• CRO News
  

  PRA Health Sciences Expands Pharmacovigilance Services

  Offers post-marketing services for authorized COVID-19 vaccines and therapeutics, including PASS using Real World Solutions.

  Kristin Brooks 04.22.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
  

  RDIF, Hualan Ink COVID-19 Vaccine Deal

  Deal calls for production of over 100 million doses of Sputnik V vaccine in China.

  Tim Wright, Editor, Contract Pharma 04.19.21
  

  ---

• Breaking News | Collaborations & Alliances | Industry News
  

  Kintor, Visum Enter COVID-19 Manufacturing Partnership

  To expand proxalutamide manufacturing for treatment of COVID-19 patients.

  Tim Wright, Editor, Contract Pharma 04.19.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
  

  Pfizer, BioNTech Expand COVID-19 Vaccine Agreement with EU

  EU orders 100 million additional doses of COMIRNATY, bringing total doses to 600 million for 27 EU member states.

  Tim Wright, Editor, Contract Pharma 04.19.21
  

  ---

• Breaking News | Drug Development | Industry News
  

  Bristol Myers Squibb Expands at Cambridge Crossing

  Adds remaining 113,000 square feet to its initial lease at 250 Water Street.

  Kristin Brooks 04.16.21
  

  ---

• Breaking News | CRO News
  

  Thermo Fisher Scientific to Acquire PPD

  Further expands service offering to pharma and biotech customers in high growth clinical research services industry.

  Infographics

  ---

• Breaking News | CRO News | Industry News
  

  Thermo Fisher Acquires PPD for $17.4B

  Further expands service offering to pharma and biotech customers.

  Tim Wright, Editor, Contract Pharma 04.15.21
  

  ---

• Breaking News | Collaborations & Alliances | Industry News | Solid Dosage/Creams/Ointments
  

  Recro, Ensysce Expand Development and Manufacturing Partnership

  Additional contract broadens and further strengthens customer product portfolio.

  Tim Wright, Editor, Contract Pharma 04.15.21
  

  ---

• Breaking News | Drug Development | Industry News
  

  BioVersys Gets EIB Funds to Address Antimicrobial Resistance

  Financing supports development of BioVersys’ breakthrough hospital antibiotic therapy targeting Acinetobacter baumannii

  Kristin Brooks 04.14.21
  

  ---

• Breaking News | Industry News | Microbiology
  

  Microbiologics Expands Virology Services

  Increases capabilities and capacity to provide anti-infective testing, assay development and biomaterial production services for highly infectious pathogens.

  Kristin Brooks 04.14.21
  

  ---

• Breaking News | Industry News | Microbiology
  

  Lonza Expands PyroTec PRO for Endotoxin Testing

  Aims to enable users to streamline and improve the performance of the QC laboratory, increasing lab efficiency and productivity.

  Kristin Brooks 04.12.21
  

  ---

• Breaking News | Clinical Trials | CRO News | Industry News
  

  Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

  Offers full-service human absorption, metabolism, and excretion (hAME) studies with radiolabeled compounds.

  Tim Wright, Editor, Contract Pharma 04.09.21
  

  ---

• Breaking News | Clinical Trials | CRO News
  

  Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

  Adding layer of technology to HGH treatments aims to facilitate better patient compliance.

  Kristin Brooks 04.08.21
  

  ---

• Breaking News | Clinical Trials | CRO News | Drug Development
  

  Moleculin Selects IQVIA Biotech to Advance COVID Treatment

  IQVIA to manage the company's effort to begin potential clinical trials of WP1122 for the treatment of COVID-19.

  Kristin Brooks 04.06.21
  

  ---

• Breaking News | Industry News | Promotions & Moves
  

  Recro Pharma Expands Business Development Team

  Adds six new members, including sales representatives and regional representatives.

  Charles Sternberg, Assistant Editor 04.05.21
  

  ---

• Bioanalytical Services | Breaking News | CRO News | Industry News
  

  Charles River Acquires Retrogenix

  Strengthens scientific expertise with the addition of cell microarray technology and off-target profiling for drug discovery.

  Tim Wright, Editor, Contract Pharma 04.05.21
  

  ---

• R&D
  

  Small Innovators & Niche CROs

  Smaller CROs have the opportunity to provide a niche approach to its clients, particularly smaller sponsors who have shared synergies.

  Neil Goodman, David Bruce and Mohamed El Malt, Europital 04.01.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Fill/Finish | Industry News
  

  GSK Supports Manufacture of Novavax’ COVID-19 Vaccine

  GSK will provide fill and finish manufacturing capacity for up to 60 million doses at its Barnard Castle facility.

  Tim Wright, Editor, Contract Pharma 03.31.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer
  

  CureVac, Celonic Enter COVID-19 Vax Mfg. Pact

  Celonic is prepared to manufacture more than 100 million doses of CureVac’s mRNA-based COVID-19 vaccine candidate, CVnCoV, per year at Heidelberg facility.

  Kristin Brooks 03.30.21
  

  ---

• Biologics, Proteins, Vaccines | cGMP Manufacture
  

  Advanced Analytics Advancing Development of Genetic Vaccines

  Leveraging innovative advanced analytical technologies to ensure regulatory compliance in the development and production of novel vaccines.

  Online Exclusives Kristin Brooks, Managing Editor, Contract Pharma 03.29.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Fill/Finish | Industry News | Parenterals
  

  Jubilant, Novavax Enter COVID-19 Vaccine Partnership

  Jubilant to provide fill-finish manufacturing services for the production of COVID-19 vaccine candidate NVX-CoV2373.

  Tim Wright, Editor, Contract Pharma 03.29.21
  

  ---

• Breaking News | cGMP Manufacture | Industry News
  

  EMA Approves BioNTech's COVID Vax Production at Marburg Site

  Largest mRNA vaccine manufacturing site in Europe has annual production capacity of up to one billion doses of its COVID-19 vaccine.

  Kristin Brooks 03.26.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Industry News
  

  CyanVac and Exothera Enter COVID-19 Vaccine Partnership

  CDMO Exothera selected for the development and GMP manufacturing of intranasal vaccine candidate for Phase III clinical trial is Europe and the U.S.

  Tim Wright, Editor, Contract Pharma 03.25.21
  

  ---

• Clinical Trials | CRO News | Information Technology
  

  PPD, Clinical Ink Partner on Near Real-Time Access to Endpoint Data

  Jointly develop systemic lupus erythematosus assessment review process to enhance data quality and research site personnel experiences and efficiencies.

  Kristin Brooks 03.24.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
  

  RDIF & Stelis Enter Covid-19 Vaccine Supply Deal

  Partner to supply 200 million doses of the Sputnik V vaccine.

  Tim Wright, Editor, Contract Pharma 03.19.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
  

  Catalent Expands Partnership with J&J

  To significantly increase capacity for sterile manufacturing and packaging of COVID-19 vaccine in Italy.

  Tim Wright, Editor, Contract Pharma 03.17.21
  

  ---

• Breaking News | Clinical Trial Materials | CRO News
  

  LabConnect Expands Johnson City Facility

  Central lab to add 20,000 sq.-ft., tripling kit building capacity for complex clinical studies along with other planned operational improvements.

  Kristin Brooks 03.16.21
  

  ---

• Breaking News | Clinical Trials | Drug Development | Trials & Filings
  

  Cytocom Gets FDA Clearance for Phase II Trial of COVID Immune Therapy

  Phase 2 clinical trial to evaluate the safety and efficacy of CYTO-205 as a treatment to slow or halt the progression of SARS-CoV-2.

  Kristin Brooks 03.16.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
  

  Tevogen Bio, BioCentriq Partner for COVID T-cell Therapy

  NJ-based cell and gene therapy development and manufacturing center to support clinical manufacturing of Tevogen’s investigational COVID-19 treatment.

  Kristin Brooks 03.16.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
  

  Takeda and IDT Support Manufacturing of J&J’s COVID-19 Vaccine

  Will make manufacturing capacity available at IDT’s facilities in Germany to manufacture the single-shot COVID-19 vaccine.

  Tim Wright, Editor, Contract Pharma 03.15.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
  

  Maravai Expands CDMO Capabilities Through TriLink Biotechnologies

  Offers end-to-end mRNA production with the launch of TriLink's plasmid DNA manufacturing services.

  Tim Wright, Editor, Contract Pharma 03.15.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
  

  BioVaxys, Wuxi Biologics Enter Bioproduction Agreement

  To synthesize proteins for SARS-CoV-2 vaccine and COVID-T immunodiagnostic programs.

  Tim Wright, Editor, Contract Pharma 03.15.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Industry News
  

  Novavax Confirms Efficacy Against Original and Variant COVID-19 Strains

  Final analysis of NVX–CoV2373 in UK trial confirms 96% efficacy against original strain of COVID-19 and 86.3% against the B.1.1.7 variant.

  Kristin Brooks 03.12.21
  

  ---

• Breaking News | cGMP Manufacture | Industry News
  

  Altimmune, Lonza Expand AdCOVID Manufacturing Pact

  Lonza to commission a dedicated suite for clinical and commercial supply of Altimmune’s COVID-19 vaccine candidate at its Houston facility.

  Kristin Brooks 03.12.21
  

  ---

• Breaking News | Trials & Filings
  

  Lilly's COVID Therapy Boasts Robust New Results

  Phase 3 trial data shows bamlanivimab and etesevimab reduces the risk of COVID-related hospitalization and death by 87%.

  Kristin Brooks 03.10.21
  

  ---

• Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
  

  Jubilant HollisterStier, Lilly Enter Bamlanivimab Mfg. Pact

  COVID-19 therapy Bamlanivimab will be manufactured at Jubilant HollisterStier's Spokane, WA facility.

  03.09.21
  

  ---